ZA717083B - New pharmaceutical compositions - Google Patents

New pharmaceutical compositions

Info

Publication number
ZA717083B
ZA717083B ZA717083A ZA717083A ZA717083B ZA 717083 B ZA717083 B ZA 717083B ZA 717083 A ZA717083 A ZA 717083A ZA 717083 A ZA717083 A ZA 717083A ZA 717083 B ZA717083 B ZA 717083B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical compositions
new pharmaceutical
new
compositions
pharmaceutical
Prior art date
Application number
ZA717083A
Other languages
English (en)
Inventor
W Kampe
M Thiel
E Fauland
H Stork
F Schmidt
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of ZA717083B publication Critical patent/ZA717083B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
ZA717083A 1970-10-27 1971-10-22 New pharmaceutical compositions ZA717083B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19702052596 DE2052596A1 (de) 1970-10-27 1970-10-27 Neuartige Verwendung von N(6)-substituierten Adenosin-Derivaten

Publications (1)

Publication Number Publication Date
ZA717083B true ZA717083B (en) 1972-08-30

Family

ID=5786241

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA717083A ZA717083B (en) 1970-10-27 1971-10-22 New pharmaceutical compositions

Country Status (9)

Country Link
US (1) US3851056A (xx)
AU (1) AU450603B2 (xx)
BE (1) BE774399A (xx)
CA (1) CA983395A (xx)
DE (1) DE2052596A1 (xx)
FR (1) FR2111862B1 (xx)
GB (1) GB1325970A (xx)
IL (1) IL37975A (xx)
ZA (1) ZA717083B (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1239397A (en) * 1983-08-01 1988-07-19 James A. Bristol N.sup.6-substituted adenosines
DE3406533A1 (de) * 1984-02-23 1985-08-29 Boehringer Mannheim Gmbh, 6800 Mannheim Verwendung von adenosin-derivaten als antiallergica und arzneimittel, die diese enthalten
ATE50777T1 (de) * 1984-04-18 1990-03-15 Whitby Research Inc Cardio-vasodilatatore n-6-substituierte adenosine.
US5310731A (en) * 1984-06-28 1994-05-10 Whitby Research, Inc. N-6 substituted-5'-(N-substitutedcarboxamido)adenosines as cardiac vasodilators and antihypertensive agents
US5284834A (en) * 1985-03-29 1994-02-08 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Adenosine functionalized congeners as cardiovascular treating agents for animals and methods for using same
US5565566A (en) * 1987-04-24 1996-10-15 Discovery Therapeutics, Inc. N6 -substituted 9-methyladenines: a new class of adenosine receptor antagonists
US5066655A (en) * 1987-04-24 1991-11-19 Whitby Research, Inc. N6-substituted 9-methyladenines: a new class of adenosine receptor antagonists
GB8729994D0 (en) * 1987-12-23 1988-02-03 Glaxo Group Ltd Chemical compounds
US5292725A (en) * 1988-08-25 1994-03-08 Prendergast Patrick T Administering particular compounds against various parasites, mycoplasmas, other indications and other infections
IE882585L (en) * 1988-08-25 1990-02-25 Prendergast Patrick T Viral treatment system
US5030624A (en) * 1988-10-26 1991-07-09 G. D. Searle & Co. R-diastereomer of an N6 -[(2-hydroxypropyl)aryl]adenosine and its medicinal uses
US5032584A (en) * 1988-10-26 1991-07-16 G. D. Searle & Co. S-diastereomer of an n6 -((2-hydroxypropyl)aryl)adenosine and its medicinal uses
US5055569A (en) * 1989-10-19 1991-10-08 G. D. Searle & Co. N-(6)-substituted adenosine compounds
FR2665362B1 (fr) * 1990-08-03 1994-12-09 Cepbepe Substance contenant, comme principe actif, une adenosine substitutee en n6 et son application.
DK62692D0 (xx) * 1992-05-14 1992-05-14 Novo Nordisk As
US6784165B1 (en) 1999-11-23 2004-08-31 Aderis Pharmaceuticals, Inc. Treatment of heart rhythm disturbances with N6-substituted-5′-(N-substituted) carboxamidoadenosines
MXPA05011428A (es) * 2003-04-24 2006-05-31 Aderis Pharmaceuticals Inc Metodo de tratamiento de fibrilacion atrial o trepidacion auricular.
WO2005020892A2 (en) * 2003-08-08 2005-03-10 Mitochroma Research, Inc. Pharmaceutical compositions and methods for metabolic modulation
WO2005025545A2 (en) * 2003-09-17 2005-03-24 Aderis Pharmaceuticals, Inc. Pharmaceutical formulation for controlled release of selodenoson
CN105085594A (zh) * 2014-05-23 2015-11-25 中国医学科学院药物研究所 N6-(1-(4-甲氧基苯基)乙基)-腺苷的制备及用途

Also Published As

Publication number Publication date
BE774399A (fr) 1972-04-25
US3851056A (en) 1974-11-26
DE2052596A1 (de) 1972-05-04
FR2111862B1 (xx) 1975-08-01
AU3497171A (en) 1973-05-03
CA983395A (en) 1976-02-10
FR2111862A1 (xx) 1972-06-09
IL37975A0 (en) 1971-12-29
IL37975A (en) 1975-03-13
GB1325970A (en) 1973-08-08
AU450603B2 (en) 1974-07-11

Similar Documents

Publication Publication Date Title
AU461209B2 (en) Pharmaceutical compositions
ZA713539B (en) Pharmaceutical compositions
ZA717083B (en) New pharmaceutical compositions
IE34966L (en) Pharmaceutical composition containing substitiuted¹biguanides
ZA71306B (en) Rubber-polyester compositions
IE35838B1 (en) Pharmaceutical compositions
ZA718014B (en) Pharmaceutical formulations
AU2682871A (en) Pharmaceutical compositions
ZA713877B (en) Pharmaceutical composition
CA969953A (en) Pharmaceutical compositions
GB1373913A (en) Pharmaceutical compositions
ZA715832B (en) Pharmaceutical compositions
CY938A (en) Pharmaceutical antilipidemic compositions
ZA716461B (en) Pharmaceutical compositions
ZA717694B (en) Catatoxic compositions
IE35495L (en) Pharmaceutical compositions.
ZA718200B (en) Pharmaceutical compositions
IE35713L (en) Pharmaceutical compositions
ZA715623B (en) Pharmaceutical compositions
ZA716111B (en) Rubber-polyester compositions
ZA711108B (en) Rubber-polyester compositions
AU456863B2 (en) Pharmaceutical compositions
CA845684A (en) Pharmaceutical compositions
AU449539B2 (en) Pharmaceutical compositions
AU458685B2 (en) Pharmaceutical compositions